immunity News and Research

RSS

Vaccine effectiveness of BNT162b2 third dose against COVID-19

A group of researchers from Maccabi Healthcare Services performed a retrospective cohort study to determine vaccine effectiveness of a third dose.

8 Nov 2021

More than 10 million people in the UK receive COVID-19 booster jabs

More than 10 million people have now received their COVID-19 booster or third jabs, the latest figures show, ensuring the vital protection they have secured from their first two doses is maintained over the winter months.

8 Nov 2021

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

The importance of exercise for those with diabetes in the COVID era

A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.

7 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

Health and Social Care Secretary Sajid Javid has called for the UK to come together to help vaccinate those most vulnerable to COVID-19 with booster jabs.

7 Nov 2021

Booster booking system changed to make it easier for people to get their jab

The government and the NHS have changed the booster booking system to make it even easier for people to get their jab.

7 Nov 2021

Research shows how inflammatory reactions can be resolved by changes to metabolism of macrophages

New data from a research team at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) shows how inflammatory reactions can be resolved by changes to the metabolism of macrophages.

7 Nov 2021

Study discovers how the immune system triggers an 'emergency' dendritic cell response during infection

Scientists at the Francis Crick Institute have found how the immune system triggers an 'emergency' dendritic cell response during infection, with dendritic cells at the site of infection being reinforced by new cells which travel from the bone marrow.

6 Nov 2021

New type of COVID vaccine potentially easier to produce and does not need refrigeration

Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.

6 Nov 2021

Key link between chronic stress and cancer discovered

Stress can have a significant negative effect on health, but our understanding of how stress impacts the development and progression of cancer is just beginning.

6 Nov 2021

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

A new preprint describes the protective efficacy of memory T-cells developed in response to the viral antigen, which could offer long-term immunity.

4 Nov 2021

Study shows most young Australians are willing to be tested for COVID

A new study explores the success of testing efforts among children and adolescents in Australia.

4 Nov 2021

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

A new study describes the results of the safety and efficacy phase trials of a new COVID-19 vaccine from Cuba.

4 Nov 2021

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

The study, recently published in The Journal of the American Medical Association, deduced that previous SARS-CoV-2 infection is associated with a statistically significant reduced hazard of breakthrough infection among recipients of both the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna) vaccines.

3 Nov 2021

immunity News and Research

Vaccine effectiveness of BNT162b2 third dose against COVID-19

More than 10 million people in the UK receive COVID-19 booster jabs

Pacific oyster as a weapon against SARS-CoV-2

The importance of exercise for those with diabetes in the COVID era

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

Booster booking system changed to make it easier for people to get their jab

Research shows how inflammatory reactions can be resolved by changes to metabolism of macrophages

Study discovers how the immune system triggers an 'emergency' dendritic cell response during infection

New type of COVID vaccine potentially easier to produce and does not need refrigeration

Key link between chronic stress and cancer discovered

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

Study shows most young Australians are willing to be tested for COVID

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Cross-reactive immunity against coronaviruses

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News